Article List

WPRIM Management System> DCMS> Gut and Liver> 2017> 11> 5

Volume: 11 Issue: 5

1. Risk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy.	Page:612—619
2. Risk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy.	Page:612—619
3. Endoscopic Management of Peri-Pancreatic Fluid Collections.	Page:604—611
4. Endoscopic Management of Peri-Pancreatic Fluid Collections.	Page:604—611
5. Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives.	Page:590—603
6. Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives.	Page:590—603
7. Gastroparesis Updates on Pathogenesis and Management.	Page:579—589
8. Gastroparesis Updates on Pathogenesis and Management.	Page:579—589
9. Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease.	Page:577—578
10. Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease.	Page:577—578
11. Atrophic Gastritis Increases the Risk of Gastric Cancer in Asymptomatic Population in Korea.	Page:575—576
12. Atrophic Gastritis Increases the Risk of Gastric Cancer in Asymptomatic Population in Korea.	Page:575—576
13. The Advantage of an Endoscopic Submucosal Tunneling Technique for Rectal Carcinoid Tumors.	Page:735—737
14. Active Helicobacter pylori Infection Is a Risk Factor for Colorectal Mucosa: Early and Advanced Colonic Neoplasm Sequence.	Page:733—734
15. Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer.	Page:728—732
16. Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naïve or Treatment-Experienced.	Page:721—727
17. Real-World Single-Center Experience with Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C Genotype 1 Patients.	Page:711—720
18. Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study.	Page:702—710
19. Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation.	Page:693—701
20. Nomograms to Predict the Individual Survival of Patients with Solitary Hepatocellular Carcinoma after Hepatectomy.	Page:684—692
21. Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease.	Page:674—683
22. Advanced Colonic Neoplasia at Follow-up Colonoscopy According to Risk Components and Adenoma Location at Index Colonoscopy: A Retrospective Study of 1,974 Asymptomatic Koreans.	Page:667—673
23. Heme Oxygenase-1 Induction and Anti-inflammatory Actions of Atractylodes macrocephala and Taraxacum herba Extracts Prevented Colitis and Was More Effective than Sulfasalazine in Preventing Relapse.	Page:655—666
24. In Vitro Activity of Diphenyleneiodonium toward Multidrug-Resistant Helicobacter pylori Strains.	Page:648—654
25. Comparison of the Outcomes of Peroral Endoscopic Myotomy for Achalasia According to Manometric Subtype.	Page:642—647
26. Postoperative Helicobacter pylori Infection as a Prognostic Factor for Gastric Cancer Patients after Curative Resection.	Page:635—641
27. Characteristics of Primary and Metachronous Gastric Cancers Discovered after Helicobacter pylori Eradication: A Multicenter Propensity Score-Matched Study.	Page:628—634
28. Endoscopic Submucosal Tunnel Dissection for Upper Gastrointestinal Submucosal Tumors Originating from the Muscularis Propria Layer: A Single-Center Study.	Page:620—627